These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12502880)

  • 1. Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif.
    Fujita M; Sakurai A; Yoshida A; Miyaura M; Koyama AH; Sakai K; Adachi A
    J Virol; 2003 Jan; 77(2):1626-32. PubMed ID: 12502880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
    Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F
    J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity.
    Ma XY; Sova P; Chao W; Volsky DJ
    J Virol; 1994 Mar; 68(3):1714-20. PubMed ID: 8107232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique characteristics of HIV-1 Vif expression.
    Wang H; Sakurai A; Khamsri B; Uchiyama T; Gu H; Adachi A; Fujita M
    Microbes Infect; 2005 Mar; 7(3):385-90. PubMed ID: 15784183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.
    Madani N; Kabat D
    J Virol; 1998 Dec; 72(12):10251-5. PubMed ID: 9811770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent lack of trans-dominant negative effects of various vif mutants on the replication of HIV-1.
    Fujita M; Matsumoto S; Sakurai A; Doi N; Miyaura M; Yoshida A; Adachi A
    Microbes Infect; 2002 Oct; 4(12):1203-7. PubMed ID: 12467760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.
    Kao S; Akari H; Khan MA; Dettenhofer M; Yu XF; Strebel K
    J Virol; 2003 Jan; 77(2):1131-40. PubMed ID: 12502829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants.
    Fujita M; Sakurai A; Doi N; Miyaura M; Yoshida A; Sakai K; Adachi A
    Microbes Infect; 2001 Nov; 3(13):1093-9. PubMed ID: 11709289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of human immunodeficiency virus type 1 vif gene.
    Sakai K; Horiuchi M; Iida S; Fukumori T; Akari H; Adachi A
    Virus Genes; 1999; 18(2):179-81. PubMed ID: 10403705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
    Zhang H; Pomerantz RJ; Dornadula G; Sun Y
    J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementation of human immunodeficiency virus type 1 vif mutants in some CD4+ T-cell lines.
    Hevey M; Donehower LA
    Virus Res; 1994 Sep; 33(3):269-80. PubMed ID: 7527173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child.
    Alexander L; Aquino-DeJesus MJ; Chan M; Andiman WA
    J Virol; 2002 Oct; 76(20):10533-9. PubMed ID: 12239333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free transmission of Vif mutants of HIV-1.
    Fan L; Peden K
    Virology; 1992 Sep; 190(1):19-29. PubMed ID: 1529528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.
    Madani N; Kabat D
    J Virol; 2000 Jul; 74(13):5982-7. PubMed ID: 10846079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lysine to arginine mutations in HIV-1 Vif on its expression and viral infectivity.
    Khamsri B; Fujita M; Kamada K; Piroozmand A; Yamashita T; Uchiyama T; Adachi A
    Int J Mol Med; 2006 Oct; 18(4):679-83. PubMed ID: 16964423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation.
    Fujita M; Akari H; Sakurai A; Yoshida A; Chiba T; Tanaka K; Strebel K; Adachi A
    Microbes Infect; 2004 Jul; 6(9):791-8. PubMed ID: 15374000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a functionally important amino acid residue near to the amino-terminus of the human immunodeficiency virus type 1 Vif protein.
    Boyce M; Willingmann P; McCrae M
    Virus Genes; 1999; 19(1):15-22. PubMed ID: 10499446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host cell-dependent replication of HIV-1 mutants with deletions in gp41 cytoplasmic tail region is independent of the function of Vif.
    Akari H; Yoshida A; Fukumori T; Adachi A
    Microbes Infect; 2000 Jul; 2(9):1019-23. PubMed ID: 11032465
    [No Abstract]   [Full Text] [Related]  

  • 20. The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis.
    Nascimbeni M; Bouyac M; Rey F; Spire B; Clavel F
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1945-50. PubMed ID: 9714242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.